Sleep

Posttraumatic stress disorder (PTSD) symptoms and insomnia might be sex specific, and it is important to screen patients diagnosed with chronic insomnia for PTSD symptoms.

In part 2 of this 4-part series, Michael Thorpy, MD, discusses cases when a higher salt intake can be beneficial for some patients who have narcolepsy or daytime sleepiness.

Automated ventilatory burden can effectively assess obstructive sleep apnea (OSA) severity, estimate cardiovascular (CVD) mortality, and may present a promising alternative to apnea-hypopnea index (AHI).

Insomnia, along with other sleep disorders, were found to negatively impact workplace productivity.

In part 1 of this 4 part series, Michael Thorpy, MD, talks about salt intake and how health guidelines and individual habits shape what kind of medication is right for patients with sleep disorders like excessive daytime sleepiness or narcolepsy.

Poor quality of life and impaired functioning across many symptom domains were shown in participants in the Real World Idiopathic Hypersomnia Outcomes Study (ARISE).

Periodic limb movements during sleep (PLMS) are an added risk factor for cardiovascular disease in obstructive sleep apnea (OSA), recent study findings suggest.

It is reasonable to view stimulus control as an effective insomnia treatment, particularly for sleep initiation problems.

Sheila Garland, PhD, MSc, Memorial University in Newfoundland, Canada talks about the cognitive effects cancer can have on patients, beyond treatment side effects, and the direct impacts these can make on patients’ lives and care.

Maternal sleep duration and self-efficacy might be modifiable risk factors of maternal depression, possibly providing treatment opportunities.

Sleep processes and emotional processes are closely related, especially in terms of insomnia.

Dayna Johnson, PhD, MPH, MSW, MS talks about the necessity of community partnerships as the recipient of this year’s Associated Professional Sleep Societies (APSS) Diversity, Equity, and Inclusion Leadership Award at SLEEP 2023 and how inquiring into the community is vital for integrating healthy sleep practices.

Stress can harm different areas of sleep health in young adults who are good sleepers.

A systematic review and meta-analysis of the effects of caffeine on sleep aimed to help determine clear guidelines.

Judite Blanc, PhD, is lead author on the abstract, “Social Determinants of Sleep Disorders Among Multiethnic Americans in the NIH All of Us Research Program,” which was presented on June 5th at the SLEEP 2023 conference.

Poor sleep quality might cause cognitive difficulties, while REM sleep might be protective against these difficulties, highlighting the usefulness of a simple neurocognitive screening tool for patients with persistent insomnia disorder (pID).

Acceptance and commitment therapy can significantly help patients with primary insomnia and secondary symptoms, especially anxiety associated with insomnia and those who have not responded to cognitive behavioral therapy for insomnia.

Obstructive sleep apnea (OSA) could contribute to mood worsening in patients with OSA and chronic insomnia (CI).

Judite Blanc, PhD, University of Miami Miller School of Medicine, discusses how total sleep needs vary among ages and the consequences of these changing hourly totals.

Healthy sleep before being infected with SARS-CoV-2 infection and before and during the COVID-19 pandemic might protect against post–COVID-19 condition, or long COVID.

Idiopathic hypersomnia treatment should be determined based on factors like symptom profile, age, comorbidities, and additional medications, says review.

In this interview from SLEEP 2023, Andrew McHill, PhD, of Oregon Health and Science University (OHSU), explains the importance of individualizing sleep hygiene recommendations.

Certain sleep difficulties present in the transition from childhood to adolescence might be associated with psychopathology symptoms.

Adolescents can substantially increase sleep duration by advancing their bedtime, study shows.

Patients who are members of racial minority groups are less likely to be prescribed insomnia medication.